Drug Approval Package
-
Evista (raloxifene hydrochloride) Tablets, 60 mg.
Company: Eli Lilly and Company
NDA: 022042
Approval Date: 9/13/2007
Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.
- Approval Letter(s) (PDF)
- Printed Labeling (PDF)
- Medical Review(s)
- Chemistry Review(s) (PDF)
- Statistical Review(s) (PDF)
- Clinical Pharmacology Biopharmaceutics Review(s) (PDF)
Date created: March 12, 2009
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-